VF
WHWK

Virtu Financial’s Whitehawk Therapeutics WHWK Stock Holding History

Virtu Financial’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,580
Closed -$40K – 1990
2024
Q2 		$40K Buy
+27,580
New +$51.1K ﹤0.01% 936
2023
Q4 		– Sell
-14,947
Closed -$72K – 2104
2023
Q3 		$72K Buy
+14,947
New +$86.9K 0.01% 874
2021
Q3 		– Sell
-3,125
Closed -$79K – 2061
2021
Q2 		$79K Sell
3,125
-2,362
-43% -$54K 0.01% 1255
2021
Q1 		$106K Sell
5,487
-5,919
-52% -$136K 0.01% 1305
2020
Q4 		$168K Buy
11,406
+8,943
+363% +$191K 0.02% 915
2020
Q3 		$55K Buy
+2,463
New +$51.8K 0.01% 812
2019
Q4 		$23K Buy
+2,470
New +$20.6K ﹤0.01% 1307

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's WHWK Position: Q3 2024 in Review

Virtu Financial sold out of Whitehawk Therapeutics (WHWK) in Q3 2024, closing a stake of 27,580 shares — an estimated $40K sold.

Virtu Financial first reported a position in WHWK in Q4 2019 and held it in 7 quarters. The position peaked at $168K in Q4 2020. 52 funds tracked by Wall St. Rank hold WHWK as of Q3 2024.

  • Virtu Financial reported no remaining Whitehawk Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 27,580 Whitehawk Therapeutics shares in Q3 2024, an estimated $40K.
  • Virtu Financial first reported a position in Whitehawk Therapeutics in Q4 2019 and held it in 7 quarters.
  • Virtu Financial's Whitehawk Therapeutics position peaked at $168K in Q4 2020.
  • 52 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.